Biossil
-
Malvern-Based Galera Therapeutics Sells Drug Portfolio for Up to $105 Million
Following an FDA setback, Malvern-based Galera Therapeutics is selling its drug portfolio to the Canadian biotechnology firm Biossil in a deal that has been valued…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
